Imen Guella, Nageeb Hassan, Moyad Shahwan, Yaser Mohammed Al-Worafi, Sahab Alkhoujah
firstname.lastname@example.org , email@example.com , firstname.lastname@example.org
Imen Guella1, Nageeb Hassan1,2, Moyad Shahwan1,2, Yaser Mohammed Al-Worafi3, Sahab Alkhoujah1
1College of Pharmacy, Ajman University, Ajman, UAE.
2Centre of Medical and Bio-allied Health Sciences Research.
3College of Pharmacy, University of Science and Technology of Fujairah, Fujairah, UAE.
Volume - 14,
Issue - 6,
Year - 2021
Objectives: Patients play an important role in activating the generic medicine policy as their acceptance of it reported as an essential factor. Therefore, this study aimed to explore the beliefs of patients in the UAE towards generic medicines and to identify the factors affecting their beliefs towards generic medicines. Methods: A cross-sectional study was conducted between 1st March and 1st June 2016. A self-administered questionnaire was distributed to 600 adult patients in Ajman and Sharjah, United Arab Emirates. The data were analyzed using Statistical Package for the Social Sciences® (IBM SPSS) version 21 for Windows. Results: 500 patients participated in this study. The findings of this study found that 44% of patients understand the difference between generic and branded medicines. The majority of patients in this study didn’t know that the efficacy and safety of generic medicines are the same as branded medicines. The majority of patients in this study were not familiar with the similarity and differences between generic medicines and branded medicines. Conclusion: The current study found that the patients had negative beliefs towards generic medicines. The findings of this study found that the following factors contributed to the patients’ beliefs towards generic medicines: gender, age, education level, and monthly income.
Cite this article:
Imen Guella, Nageeb Hassan, Moyad Shahwan, Yaser Mohammed Al-Worafi, Sahab Alkhoujah. Patients’ beliefs towards generic medicines in the United Arab Emirates. Research Journal of Pharmacy and Technology. 2021; 14(6):3343-6. doi: 10.52711/0974-360X.2021.00581
Imen Guella, Nageeb Hassan, Moyad Shahwan, Yaser Mohammed Al-Worafi, Sahab Alkhoujah. Patients’ beliefs towards generic medicines in the United Arab Emirates. Research Journal of Pharmacy and Technology. 2021; 14(6):3343-6. doi: 10.52711/0974-360X.2021.00581 Available on: https://rjptonline.org/AbstractView.aspx?PID=2021-14-6-71
1. Dunne S, Shannon B, Dunne C, Cullen W. A review of the differences and similarities between generic drugs and their originator counterparts, including economic benefits associated with usage of generic medicines, using Ireland as a case study. BMC Pharmacol Toxicol. 2013; 14(1): 1.
2. World Health Organization. Drug Information/Generic medicines. Available from: https://www.who.int/medicines/ publications/druginformation/issues/DrugInformation2016_Vol30-3/en/.
3. World Health Organization/Hai Global. Medicine prices, availability, affordability and price components, A synthesis report of medicine price surveys undertaken in selected countries of the WHO Eastern Mediterranean Region/Cairo, WHO. Regional Office for the Eastern Mediterranean. Available from: https://apps.who.int/iris/handle/10665/116567
4. Al-Worafi YM. Pharmacy practice and its challenges in Yemen. The Australasian Medical Journal. 2014; 7(1): 17-23.
5. Al-Worafi YM. Pharmacy practice in Yemen. In Pharmacy Practice in Developing Countries, Achievements and Challenges, Edited by Ahmed Ibrahim Fathelrahman, Mohamed Izham Mohamed Ibrahim and Albert I. Academic Press. 2016; 1st ed: pp. 267-287.
6. IMS Health. Generic Medicines: Essential contributors to the long-term health of society- sector sustainability challenges in Europe. Available from: https://www.medicinesforeurope.com/ 2010/03/21/generic-medicines-essential-contributor-to-the-long-term-health-of-society/.
7. Howland RH. What makes a generic medication generic? Journal of psychosocial nursing and mental health services. 2009 Dec 1; 47(12): 17-20.
8. Johnston A, et al. Generic and therapeutic substitution: a viewpoint on achieving best practice in Europe. British Journal of Clinical Pharmacology. 2011 Nov 1; 72(5): 727-30.
9. King DR, Kanavos P. Encouraging the use of generic medicines: implications for transition economies. Croatian Medical Journal. 2002 Aug 1; 43(4): 462-9.
10. Godman B, et al. Use of generics-a critical cost containment measure for all healthcare professionals in Europe?. Pharmaceuticals. 2010 Aug 5;3(8):2470-94.
11. Al Ameri MN, et al. Renal patients' views on generic prescribing and substitution: example from the United Arab Emirates. 2013; 19(4): 373-381.
12. Hamed H, et al. The impact of implementing HAAD generic drug policy. Journal of Critical Care. 2010 Dec 1; 25(4): 13-4.
13. Dylst P, Vulto A, Simoens S. Demand-side policies to encourage the use of generic medicines: an overview. Expert Review of Pharmacoeconomics and Outcomes Research. 2013 Feb 1; 13(1): 59-72.
14. Figueiras MJ, et al. Assessing lay beliefs about generic medicines: Development of the generic medicines scale. Psychology, Health and Medicine. 2009 May 1; 14(3): 311-21.
15. Al-Mohamadi A, et al. Medical and Pharmacy Students’ Perceptions Regarding Generic Medicines in Yemen. Journal of Pharmacy Practice and Community Medicine. 2018; 4(2): 47-50.
16. Sharif SI, et al. Evaluation of the Knowledge and Perceptions of Patients towards Generic Medicines in UAE. Pharmacology and Pharmacy. 2016 Sep 1; 7(9): 369.
17. Thomas R, Vitry A. Consumers’ perception of generic medicines in community pharmacies in Malaysia. South Med Rev. 2009 Sep 1; 2(2): 20-3.
18. Kohli E, Buller A. Factors influencing consumer purchasing patterns of generic versus brand name over-the-counter drugs. South Med J. 2013 Feb 1; 106(2): 155-60.
19. Alrasheedy AA, et al. Patient knowledge, perceptions, and acceptance of generic medicines: a comprehensive review of the current literature. Patient Intell. 2014 Apr 1; 6: 1-29.
20. Kobayashi E, et al. Patients’ attitudes towards generic drug substitution in Japan. Health Policy. 2011 Jan 1; 99(1): 60-5.
21. Quintal C, Mendes P. Underuse of generic medicines in Portugal: an empirical study on the perceptions and attitudes of patients and pharmacists. Health Policy. 2012 Jan 1; 104(1): 61-8.
22. Kaplan WA, et al. Policies to promote use of generic medicines in low and middle-income countries: a review of published literature, 2000–2010. Health Policy. 2012 Aug 1; 106(3): 211-24.